Global Nifedipine Market Growth 2020-2025
According to this study, over the next five years the Nifedipine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nifedipine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nifedipine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Nifedipine, covering the supply chain analysis, impact assessment to the Nifedipine market size growth rate in several scenarios, and the measures to be undertaken by Nifedipine companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Primary Pulmonary Hypertension
Heart Failure
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Actavis
Pfizer
Shyndec
Teva
Yabao
Honglin
Huanghai
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nifedipine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Nifedipine market by identifying its various subsegments.
Focuses on the key global Nifedipine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nifedipine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nifedipine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nifedipine Consumption 2015-2025
2.1.2 Nifedipine Consumption CAGR by Region
2.2 Nifedipine Segment by Type
2.2.1 Nifedipine Controlled Release Tablets
2.2.2 Nifedipine Extended Action Tablets
2.3 Nifedipine Consumption by Type
2.3.1 Global Nifedipine Consumption Market Share by Type (2015-2020)
2.3.2 Global Nifedipine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Nifedipine Sale Price by Type (2015-2020)
2.4 Nifedipine Segment by Application
2.4.1 Primary Pulmonary Hypertension
2.4.2 Heart Failure
2.4.3 Others
2.5 Nifedipine Consumption by Application
2.5.1 Global Nifedipine Consumption Market Share by Type (2015-2020)
2.5.2 Global Nifedipine Value and Market Share by Type (2015-2020)
2.5.3 Global Nifedipine Sale Price by Type (2015-2020)
3 Global Nifedipine by Company
3.1 Global Nifedipine Sales Market Share by Company
3.1.1 Global Nifedipine Sales by Company (2018-2020)
3.1.2 Global Nifedipine Sales Market Share by Company (2018-2020)
3.2 Global Nifedipine Revenue Market Share by Company
3.2.1 Global Nifedipine Revenue by Company (2018-2020)
3.2.2 Global Nifedipine Revenue Market Share by Company (2018-2020)
3.3 Global Nifedipine Sale Price by Company
3.4 Global Nifedipine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Nifedipine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Nifedipine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Nifedipine by Regions
4.1 Nifedipine by Regions
4.2 Americas Nifedipine Consumption Growth
4.3 APAC Nifedipine Consumption Growth
4.4 Europe Nifedipine Consumption Growth
4.5 Middle East & Africa Nifedipine Consumption Growth
5 Americas
5.1 Americas Nifedipine Consumption by Countries
5.1.1 Americas Nifedipine Consumption by Countries (2015-2020)
5.1.2 Americas Nifedipine Value by Countries (2015-2020)
5.2 Americas Nifedipine Consumption by Type
5.3 Americas Nifedipine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Nifedipine Consumption by Regions
6.1.1 APAC Nifedipine Consumption by Regions (2015-2020)
6.1.2 APAC Nifedipine Value by Regions (2015-2020)
6.2 APAC Nifedipine Consumption by Type
6.3 APAC Nifedipine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Nifedipine by Countries
7.1.1 Europe Nifedipine Consumption by Countries (2015-2020)
7.1.2 Europe Nifedipine Value by Countries (2015-2020)
7.2 Europe Nifedipine Consumption by Type
7.3 Europe Nifedipine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Nifedipine by Countries
8.1.1 Middle East & Africa Nifedipine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Nifedipine Value by Countries (2015-2020)
8.2 Middle East & Africa Nifedipine Consumption by Type
8.3 Middle East & Africa Nifedipine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Nifedipine Distributors
10.3 Nifedipine Customer
11 Global Nifedipine Market Forecast
11.1 Global Nifedipine Consumption Forecast (2021-2025)
11.2 Global Nifedipine Forecast by Regions
11.2.1 Global Nifedipine Forecast by Regions (2021-2025)
11.2.2 Global Nifedipine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Nifedipine Forecast by Type
11.8 Global Nifedipine Forecast by Application
12 Key Players Analysis
12.1 Bayer
12.1.1 Company Information
12.1.2 Nifedipine Product Offered
12.1.3 Bayer Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Actavis
12.2.1 Company Information
12.2.2 Nifedipine Product Offered
12.2.3 Actavis Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Actavis Latest Developments
12.3 Pfizer
12.3.1 Company Information
12.3.2 Nifedipine Product Offered
12.3.3 Pfizer Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Pfizer Latest Developments
12.4 Shyndec
12.4.1 Company Information
12.4.2 Nifedipine Product Offered
12.4.3 Shyndec Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Shyndec Latest Developments
12.5 Teva
12.5.1 Company Information
12.5.2 Nifedipine Product Offered
12.5.3 Teva Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Teva Latest Developments
12.6 Yabao
12.6.1 Company Information
12.6.2 Nifedipine Product Offered
12.6.3 Yabao Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Yabao Latest Developments
12.7 Honglin
12.7.1 Company Information
12.7.2 Nifedipine Product Offered
12.7.3 Honglin Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Honglin Latest Developments
12.8 Huanghai
12.8.1 Company Information
12.8.2 Nifedipine Product Offered
12.8.3 Huanghai Nifedipine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Huanghai Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Nifedipine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Nifedipine Controlled Release Tablets
Table 5. Major Players of Nifedipine Extended Action Tablets
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Nifedipine Consumption Market Share by Type (2015-2020)
Table 8. Global Nifedipine Revenue by Type (2015-2020) ($ million)
Table 9. Global Nifedipine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Nifedipine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Nifedipine Consumption Market Share by Application (2015-2020)
Table 13. Global Nifedipine Value by Application (2015-2020)
Table 14. Global Nifedipine Value Market Share by Application (2015-2020)
Table 15. Global Nifedipine Sale Price by Application (2015-2020)
Table 16. Global Nifedipine Sales by Company (2017-2019) (MT)
Table 17. Global Nifedipine Sales Market Share by Company (2017-2019)
Table 18. Global Nifedipine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Nifedipine Revenue Market Share by Company (2017-2019)
Table 20. Global Nifedipine Sale Price by Company (2017-2019)
Table 21. Global Nifedipine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Nifedipine Products Offered
Table 23. Nifedipine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Nifedipine Consumption by Regions 2015-2020 (MT)
Table 25. Global Nifedipine Consumption Market Share by Regions 2015-2020
Table 26. Global Nifedipine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Nifedipine Value Market Share by Regions 2015-2020
Table 28. Americas Nifedipine Consumption by Countries (2015-2020) (MT)
Table 29. Americas Nifedipine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Nifedipine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Nifedipine Value Market Share by Countries (2015-2020)
Table 32. Americas Nifedipine Consumption by Type (2015-2020) (MT)
Table 33. Americas Nifedipine Consumption Market Share by Type (2015-2020)
Table 34. Americas Nifedipine Consumption by Application (2015-2020) (MT)
Table 35. Americas Nifedipine Consumption Market Share by Application (2015-2020)
Table 36. APAC Nifedipine Consumption by Regions (2015-2020) (MT)
Table 37. APAC Nifedipine Consumption Market Share by Regions (2015-2020)
Table 38. APAC Nifedipine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Nifedipine Value Market Share by Regions (2015-2020)
Table 40. APAC Nifedipine Consumption by Type (2015-2020) (MT)
Table 41. APAC Nifedipine Consumption Market Share by Type (2015-2020)
Table 42. APAC Nifedipine Consumption by Application (2015-2020) (MT)
Table 43. APAC Nifedipine Consumption Market Share by Application (2015-2020)
Table 44. Europe Nifedipine Consumption by Countries (2015-2020) (MT)
Table 45. Europe Nifedipine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Nifedipine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Nifedipine Value Market Share by Countries (2015-2020)
Table 48. Europe Nifedipine Consumption by Type (2015-2020) (MT)
Table 49. Europe Nifedipine Consumption Market Share by Type (2015-2020)
Table 50. Europe Nifedipine Consumption by Application (2015-2020) (MT)
Table 51. Europe Nifedipine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Nifedipine Consumption by Countries (2015-2020) (MT)
Table 53. Middle East & Africa Nifedipine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Nifedipine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Nifedipine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Nifedipine Consumption by Type (2015-2020) (MT)
Table 57. Middle East & Africa Nifedipine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Nifedipine Consumption by Application (2015-2020) (MT)
Table 59. Middle East & Africa Nifedipine Consumption Market Share by Application (2015-2020)
Table 60. Nifedipine Distributors List
Table 61. Nifedipine Customer List
Table 62. Global Nifedipine Consumption Forecast by Countries (2021-2025) (MT)
Table 63. Global Nifedipine Consumption Market Forecast by Regions
Table 64. Global Nifedipine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Nifedipine Value Market Share Forecast by Regions
Table 66. Global Nifedipine Consumption Forecast by Type (2021-2025) (MT)
Table 67. Global Nifedipine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Nifedipine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Nifedipine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Nifedipine Consumption Forecast by Application (2021-2025) (MT)
Table 71. Global Nifedipine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Nifedipine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Nifedipine Value Market Share Forecast by Application (2021-2025)
Table 74. Bayer Product Offered
Table 75. Bayer Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 76. Bayer Main Business
Table 77. Bayer Latest Developments
Table 78. Bayer Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 79. Actavis Product Offered
Table 80. Actavis Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 81. Actavis Main Business
Table 82. Actavis Latest Developments
Table 83. Actavis Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 84. Pfizer Product Offered
Table 85. Pfizer Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 86. Pfizer Main Business
Table 87. Pfizer Latest Developments
Table 88. Pfizer Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 89. Shyndec Product Offered
Table 90. Shyndec Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 91. Shyndec Main Business
Table 92. Shyndec Latest Developments
Table 93. Shyndec Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Product Offered
Table 95. Teva Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 96. Teva Main Business
Table 97. Teva Latest Developments
Table 98. Teva Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 99. Yabao Product Offered
Table 100. Yabao Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 101. Yabao Main Business
Table 102. Yabao Latest Developments
Table 103. Yabao Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 104. Honglin Product Offered
Table 105. Honglin Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
Table 106. Honglin Main Business
Table 107. Honglin Latest Developments
Table 108. Honglin Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 109. Huanghai Product Offered
Table 110. Huanghai Nifedipine Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Huanghai Main Business
Table 112. Huanghai Latest Developments
Table 113. Huanghai Basic Information, Company Total Revenue (in $ million), Nifedipine Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Nifedipine
Figure 2. Nifedipine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Nifedipine Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Nifedipine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Nifedipine Controlled Release Tablets
Figure 7. Product Picture of Nifedipine Extended Action Tablets
Figure 8. Global Nifedipine Consumption Market Share by Type (2015-2020)
Figure 9. Global Nifedipine Value Market Share by Type (2015-2020)
Figure 10. Nifedipine Consumed in Primary Pulmonary Hypertension
Figure 11. Global Nifedipine Market: Primary Pulmonary Hypertension (2015-2020) (MT)
Figure 12. Global Nifedipine Market: Primary Pulmonary Hypertension (2015-2020) ($ Millions)
Figure 13. Nifedipine Consumed in Heart Failure
Figure 14. Global Nifedipine Market: Heart Failure (2015-2020) (MT)
Figure 15. Global Nifedipine Market: Heart Failure (2015-2020) ($ Millions)
Figure 16. Nifedipine Consumed in Others
Figure 17. Global Nifedipine Market: Others (2015-2020) (MT)
Figure 18. Global Nifedipine Market: Others (2015-2020) ($ Millions)
Figure 19. Global Nifedipine Consumption Market Share by Application (2015-2020)
Figure 20. Global Nifedipine Value Market Share by Application (2015-2020)
Figure 21. Global Nifedipine Sales Market Share by Company in 2017
Figure 22. Global Nifedipine Sales Market Share by Company in 2019
Figure 23. Global Nifedipine Revenue Market Share by Company in 2017
Figure 24. Global Nifedipine Revenue Market Share by Company in 2019
Figure 25. Global Nifedipine Sale Price by Company in 2019
Figure 26. Global Nifedipine Consumption Market Share by Regions 2015-2020
Figure 27. Global Nifedipine Value Market Share by Regions 2015-2020
Figure 28. Americas Nifedipine Consumption 2015-2020 (MT)
Figure 29. Americas Nifedipine Value 2015-2020 ($ Millions)
Figure 30. APAC Nifedipine Consumption 2015-2020 (MT)
Figure 31. APAC Nifedipine Value 2015-2020 ($ Millions)
Figure 32. Europe Nifedipine Consumption 2015-2020 (MT)
Figure 33. Europe Nifedipine Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Nifedipine Consumption 2015-2020 (MT)
Figure 35. Middle East & Africa Nifedipine Value 2015-2020 ($ Millions)
Figure 36. Americas Nifedipine Consumption Market Share by Countries in 2019
Figure 37. Americas Nifedipine Value Market Share by Countries in 2019
Figure 38. Americas Nifedipine Consumption Market Share by Type in 2019
Figure 39. Americas Nifedipine Consumption Market Share by Application in 2019
Figure 40. United States Nifedipine Consumption Growth 2015-2020 (MT)
Figure 41. United States Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Nifedipine Consumption Growth 2015-2020 (MT)
Figure 43. Canada Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Nifedipine Consumption Growth 2015-2020 (MT)
Figure 45. Mexico Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Nifedipine Consumption Market Share by Countries in 2019
Figure 47. APAC Nifedipine Value Market Share by Regions in 2019
Figure 48. APAC Nifedipine Consumption Market Share by Type in 2019
Figure 49. APAC Nifedipine Consumption Market Share by Application in 2019
Figure 50. China Nifedipine Consumption Growth 2015-2020 (MT)
Figure 51. China Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Nifedipine Consumption Growth 2015-2020 (MT)
Figure 53. Japan Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Nifedipine Consumption Growth 2015-2020 (MT)
Figure 55. Korea Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Nifedipine Consumption Growth 2015-2020 (MT)
Figure 57. Southeast Asia Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 58. India Nifedipine Consumption Growth 2015-2020 (MT)
Figure 59. India Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Nifedipine Consumption Growth 2015-2020 (MT)
Figure 61. Australia Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Nifedipine Consumption Market Share by Countries in 2019
Figure 63. Europe Nifedipine Value Market Share by Countries in 2019
Figure 64. Europe Nifedipine Consumption Market Share by Type in 2019
Figure 65. Europe Nifedipine Consumption Market Share by Application in 2019
Figure 66. Germany Nifedipine Consumption Growth 2015-2020 (MT)
Figure 67. Germany Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 68. France Nifedipine Consumption Growth 2015-2020 (MT)
Figure 69. France Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 70. UK Nifedipine Consumption Growth 2015-2020 (MT)
Figure 71. UK Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Nifedipine Consumption Growth 2015-2020 (MT)
Figure 73. Italy Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Nifedipine Consumption Growth 2015-2020 (MT)
Figure 75. Russia Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Nifedipine Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Nifedipine Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Nifedipine Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Nifedipine Consumption Market Share by Application in 2019
Figure 80. Egypt Nifedipine Consumption Growth 2015-2020 (MT)
Figure 81. Egypt Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Nifedipine Consumption Growth 2015-2020 (MT)
Figure 83. South Africa Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Nifedipine Consumption Growth 2015-2020 (MT)
Figure 85. Israel Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Nifedipine Consumption Growth 2015-2020 (MT)
Figure 87. Turkey Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Nifedipine Consumption Growth 2015-2020 (MT)
Figure 89. GCC Countries Nifedipine Value Growth 2015-2020 ($ Millions)
Figure 90. Global Nifedipine Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 91. Global Nifedipine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Nifedipine Consumption 2021-2025 (MT)
Figure 93. Americas Nifedipine Value 2021-2025 ($ Millions)
Figure 94. APAC Nifedipine Consumption 2021-2025 (MT)
Figure 95. APAC Nifedipine Value 2021-2025 ($ Millions)
Figure 96. Europe Nifedipine Consumption 2021-2025 (MT)
Figure 97. Europe Nifedipine Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Nifedipine Consumption 2021-2025 (MT)
Figure 99. Middle East & Africa Nifedipine Value 2021-2025 ($ Millions)
Figure 100. United States Nifedipine Consumption 2021-2025 (MT)
Figure 101. United States Nifedipine Value 2021-2025 ($ Millions)
Figure 102. Canada Nifedipine Consumption 2021-2025 (MT)
Figure 103. Canada Nifedipine Value 2021-2025 ($ Millions)
Figure 104. Mexico Nifedipine Consumption 2021-2025 (MT)
Figure 105. Mexico Nifedipine Value 2021-2025 ($ Millions)
Figure 106. Brazil Nifedipine Consumption 2021-2025 (MT)
Figure 107. Brazil Nifedipine Value 2021-2025 ($ Millions)
Figure 108. China Nifedipine Consumption 2021-2025 (MT)
Figure 109. China Nifedipine Value 2021-2025 ($ Millions)
Figure 110. Japan Nifedipine Consumption 2021-2025 (MT)
Figure 111. Japan Nifedipine Value 2021-2025 ($ Millions)
Figure 112. Korea Nifedipine Consumption 2021-2025 (MT)
Figure 113. Korea Nifedipine Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Nifedipine Consumption 2021-2025 (MT)
Figure 115. Southeast Asia Nifedipine Value 2021-2025 ($ Millions)
Figure 116. India Nifedipine Consumption 2021-2025 (MT)
Figure 117. India Nifedipine Value 2021-2025 ($ Millions)
Figure 118. Australia Nifedipine Consumption 2021-2025 (MT)
Figure 119. Australia Nifedipine Value 2021-2025 ($ Millions)
Figure 120. Germany Nifedipine Consumption 2021-2025 (MT)
Figure 121. Germany Nifedipine Value 2021-2025 ($ Millions)
Figure 122. France Nifedipine Consumption 2021-2025 (MT)
Figure 123. France Nifedipine Value 2021-2025 ($ Millions)
Figure 124. UK Nifedipine Consumption 2021-2025 (MT)
Figure 125. UK Nifedipine Value 2021-2025 ($ Millions)
Figure 126. Italy Nifedipine Consumption 2021-2025 (MT)
Figure 127. Italy Nifedipine Value 2021-2025 ($ Millions)
Figure 128. Russia Nifedipine Consumption 2021-2025 (MT)
Figure 129. Russia Nifedipine Value 2021-2025 ($ Millions)
Figure 130. Spain Nifedipine Consumption 2021-2025 (MT)
Figure 131. Spain Nifedipine Value 2021-2025 ($ Millions)
Figure 132. Egypt Nifedipine Consumption 2021-2025 (MT)
Figure 133. Egypt Nifedipine Value 2021-2025 ($ Millions)
Figure 134. South Africa Nifedipine Consumption 2021-2025 (MT)
Figure 135. South Africa Nifedipine Value 2021-2025 ($ Millions)
Figure 136. Israel Nifedipine Consumption 2021-2025 (MT)
Figure 137. Israel Nifedipine Value 2021-2025 ($ Millions)
Figure 138. Turkey Nifedipine Consumption 2021-2025 (MT)
Figure 139. Turkey Nifedipine Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Nifedipine Consumption 2021-2025 (MT)
Figure 141. GCC Countries Nifedipine Value 2021-2025 ($ Millions)
Figure 142. Bayer Nifedipine Market Share (2018-2020)
Figure 143. Actavis Nifedipine Market Share (2018-2020)
Figure 144. Pfizer Nifedipine Market Share (2018-2020)
Figure 145. Shyndec Nifedipine Market Share (2018-2020)
Figure 146. Teva Nifedipine Market Share (2018-2020)
Figure 147. Yabao Nifedipine Market Share (2018-2020)
Figure 148. Honglin Nifedipine Market Share (2018-2020)
Figure 149. Huanghai Nifedipine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets